Similar to its role in ovarian cancer, in addition to the regulation of invasion, migration and proliferation of tumor cells in NSCLC, COL11A1 induces the cisplatin resistance of tumor cells through overexpression and activating Smad signaling pathway (Shen et al., 2016). The gene discussed is COL11A1; the disease is neoplasm.